Table 2 Patient outcome after treatment
Characteristic | ADM group | Non-ADM group |
|---|---|---|
Tumor cell necrosis | Â | Â |
 Huvos III, IV | 40% (8/20) | 45% (9/20) |
 Huvos I, II | 60% (12/20) | 55% (11/20) |
3-year EFS | 61% (11/18) | 63.1% (12/19) |
3-year OS | 66.7% (12/18) | 73.7% (14/19) |
Non-biopsy site recurrence | 5.6% (1/18) | 10.5% (2/19) |
Tumor cells | 0/20 | 3/20 |